296 related articles for article (PubMed ID: 18159075)
1. Reactive oxygen species may have antitumor activity in metastatic melanoma.
Tuma RS
J Natl Cancer Inst; 2008 Jan; 100(1):11-2. PubMed ID: 18159075
[No Abstract] [Full Text] [Related]
2. [In vitro drug sensitivity profiling in melanoma].
Ugurel S
J Dtsch Dermatol Ges; 2008 Jul; 6(7):611. PubMed ID: 18611186
[No Abstract] [Full Text] [Related]
3. What can we learn from phase II adjuvant trials in melanoma?
Keilholz U; Suciu S; Eggermont AM
Br J Cancer; 2000 Jul; 83(1):6-7. PubMed ID: 10883660
[No Abstract] [Full Text] [Related]
4. Randomized trials in melanoma: an update.
Eggermont AM
Surg Oncol Clin N Am; 2006 Apr; 15(2):439-51. PubMed ID: 16632225
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy for metastatic melanoma.
MandarĂ M; Nortilli R; Sava T; Cetto GL
Expert Rev Anticancer Ther; 2006 Jan; 6(1):121-30. PubMed ID: 16375649
[TBL] [Abstract][Full Text] [Related]
6. Reactive oxygen species: an Achilles' heel of melanoma?
Fruehauf JP; Trapp V
Expert Rev Anticancer Ther; 2008 Nov; 8(11):1751-7. PubMed ID: 18983235
[TBL] [Abstract][Full Text] [Related]
7. Is there a role for targeting vascular endothelial growth factor/receptor axis in the treatment of patients with metastatic melanoma?
Kim KB
Cancer; 2013 Feb; 119(3):477-80. PubMed ID: 22915026
[No Abstract] [Full Text] [Related]
8. Discontinuation of melanoma combination immunotherapy.
Baker H
Lancet Oncol; 2017 Oct; 18(10):e565. PubMed ID: 28870612
[No Abstract] [Full Text] [Related]
9. Biochemotherapy for melanoma: rational therapeutics in the search for weapons of melanoma destruction.
Margolin KA
Cancer; 2004 Aug; 101(3):435-8. PubMed ID: 15274056
[No Abstract] [Full Text] [Related]
10. [New hope in metastatic melanoma treatment?].
Guillot B
Ann Dermatol Venereol; 2012 Oct; 139(10):693-4. PubMed ID: 23122388
[No Abstract] [Full Text] [Related]
11. Adjuvant interferon therapy for melanoma.
Hancock B; Wheatley K; Ives N; Gore M
J Clin Oncol; 2005 Apr; 23(10):2431; author reply 2431-2. PubMed ID: 15800339
[No Abstract] [Full Text] [Related]
12. Dual fronts poised to transform melanoma therapy.
Mullard A
Nat Rev Drug Discov; 2011 May; 10(5):325-6. PubMed ID: 21532549
[No Abstract] [Full Text] [Related]
13. Searching for the Achilles' heel of melanoma cells: new treatment modalities.
Melnikova VO; Bar-Eli M
Pigment Cell Melanoma Res; 2008 Oct; 21(5):505-6. PubMed ID: 18713130
[No Abstract] [Full Text] [Related]
14. Chemotherapy and chemoimmunotherapy for metastatic malignant melanoma: review and recent advances.
Khayat D; Coeffic D
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():238-47. PubMed ID: 10895160
[No Abstract] [Full Text] [Related]
15. [Nivolumab for metastatic melanoma-basic knowledge and clinical data].
Yamazaki N; Maeda Y
Gan To Kagaku Ryoho; 2015 Apr; 42(4):434-8. PubMed ID: 26020984
[No Abstract] [Full Text] [Related]
16. Systemic therapy for metastatic urothelial carcinoma.
Lin CC; Hsu CH; Pu YS; Vogelzang NJ
BJU Int; 2008 Apr; 101(7):795-803. PubMed ID: 18070193
[No Abstract] [Full Text] [Related]
17. Management of metastatic melanoma.
Tawbi HA; Kirkwood JM
Semin Oncol; 2007 Dec; 34(6):532-45. PubMed ID: 18083377
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant interferon therapy for melanoma: high-dose, low-dose, no dose, which dose?
Schuchter LM
J Clin Oncol; 2004 Jan; 22(1):7-10. PubMed ID: 14665612
[No Abstract] [Full Text] [Related]
19. Treatments for metastatic melanoma: synthesis of evidence from randomized trials.
Lui P; Cashin R; Machado M; Hemels M; Corey-Lisle PK; Einarson TR
Cancer Treat Rev; 2007 Dec; 33(8):665-80. PubMed ID: 17919823
[TBL] [Abstract][Full Text] [Related]
20. [Current chemo- and hormone therapy in disseminated malignant melanoma of the skin].
Akimov MA; Gershanovich ML
Vopr Onkol; 1999; 45(4):341-9. PubMed ID: 10532089
[No Abstract] [Full Text] [Related]
[Next] [New Search]